-
The Health Legacy of 9/11
People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program.
by Brad Jones
-
Life After Pediatric Brain Cancer
Survivors of pediatric brain or spinal cord tumors can have cognitive and physical impairments. Researchers say that these deficits can be minimized with the right interventions.
by Cheryl Platzman Weinstock
-
A New Guideline for Cervical Cancer Screening
Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Being Candid About Cancer
As a father with an aggressive brain cancer, I've opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
-
Sowing Seeds of Health
A program helps cancer survivors start gardens as a way to increase their vegetable consumption and physical activity.
by Ashley P. Taylor
-
What You Need to Know About DNA Testing
Before you order an at-home genetic testing kit, carefully consider the medical, psychological and legal implications.
by Tina Segura
-
The Long-Term Effects of Cancer
Adolescent and young adult cancer survivors need to be monitored for delayed treatment side effects, including problems affecting the endocrine system, researchers say.
by Cheryl Platzman Weinstock
-
Some Pancreatic Cancers Are Hereditary
A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
What Is ‘Chemo Brain’?
The National Cancer Institute's Todd Horowitz discusses cancer-related cognitive impairment.
by Anna Azvolinsky
-
Predicting Acute Myeloid Leukemia
Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
by Anna Azvolinsky
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore